Get the Stockscreener App
0.6842
7.70%
-0.0571
Clearmind Medicine Inc stock is traded at $0.6842, with a volume of 420.53K.
It is down -7.70% in the last 24 hours and down -28.14% over the past month.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
See More
Previous Close:
$0.7413
Open:
$0.601
24h Volume:
420.53K
Relative Volume:
0.47
Market Cap:
$3.74M
Revenue:
-
Net Income/Loss:
$-6.78M
P/E Ratio:
-0.016
EPS:
-42.6996
Net Cash Flow:
$-4.67M
1W Performance:
-13.99%
1M Performance:
-28.14%
6M Performance:
-28.73%
1Y Performance:
-51.13%
1-Day Range:
$0.60
$0.70
1-Week Range:
$0.60
$0.84
52-Week Range:
$0.60
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
0.6842 | 4.05M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clearmind Medicine Inc Stock (CMND) Latest News
Why Is Clearmind Stock Down Today? - Benzinga
Intraday pattern recognizer results for Clearmind Medicine Inc.Trade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
How sentiment analysis helps forecast Clearmind Medicine Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - newser.com
Clearmind Medicine receives Nasdaq non-compliance notice over equity rule By Investing.com - Investing.com South Africa
Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - The Manila Times
Clearmind Medicine receives Nasdaq non-compliance notice over equity rule - Investing.com
Why Clearmind Medicine Inc. stock could benefit from AI revolutionJuly 2025 PreEarnings & Consistent Profit Trading Strategies - newser.com
Will Clearmind Medicine Inc. (CWY0) stock hit analyst forecastsAnalyst Upgrade & Scalable Portfolio Growth Methods - newser.com
Is Clearmind Medicine Inc. (CWY0) stock a buy for dividend portfolios2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - newser.com
Will Clearmind Medicine Inc. (CWY0) stock outperform Dow JonesJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com
Is Clearmind Medicine Inc. stock positioned for long term growthJuly 2025 Pullbacks & Weekly Market Pulse Updates - newser.com
Price momentum metrics for Clearmind Medicine Inc. explained2025 Institutional Moves & Growth Focused Investment Plans - newser.com
Will Clearmind Medicine Inc. stock rally after Fed decisions2025 Institutional Moves & Safe Capital Growth Plans - fcp.pa.gov.br
What earnings margins imply for Clearmind Medicine Inc. (CWY0) stockJuly 2025 Institutional & Risk Controlled Daily Plans - newser.com
Can Clearmind Medicine Inc. (CWY0) stock double in coming yearsRisk Management & High Conviction Trade Alerts - newser.com
Applying Wyckoff theory to Clearmind Medicine Inc. stockJuly 2025 Summary & Fast Momentum Entry Tips - newser.com
Clearmind Medicine files patent application for depression treatment in South Korea - Investing.com Nigeria
Can Clearmind Medicine Inc. stock resist sector downturnsMarket Sentiment Review & Detailed Earnings Play Strategies - fcp.pa.gov.br
Is Clearmind Medicine Inc. stock supported by strong fundamentalsTrade Signal Summary & Weekly High Return Stock Forecasts - newser.com
What dividend safety score for Clearmind Medicine Inc. stockWeekly Trade Report & Free Technical Pattern Based Buy Signals - newser.com
Applying big data sentiment scoring on Clearmind Medicine Inc.Quarterly Earnings Report & Weekly Market Pulse Updates - newser.com
Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing - The Manila Times
Clearmind Medicine Inc. Expands Global IP Protection with New Patent Application for MEAI in South Korea - Quiver Quantitative
Clearmind Medicine (NASDAQ: CMND) expands IP with South Korea MEAI depression patent - Stock Titan
Strategies to average down on Clearmind Medicine Inc.Index Update & Low Drawdown Trading Techniques - newser.com
Using data models to predict Clearmind Medicine Inc. stock movementQuarterly Portfolio Report & Smart Money Movement Alerts - newser.com
Published on: 2025-11-05 00:15:14 - newser.com
Volatility clustering patterns for Clearmind Medicine Inc.July 2025 Earnings & Smart Investment Allocation Insights - newser.com
Historical volatility pattern of Clearmind Medicine Inc. visualized2025 Top Gainers & Daily Oversold Bounce Ideas - newser.com
Is Clearmind Medicine Inc. (CWY0) stock inflation resilientTrade Entry Report & Reliable Price Action Trade Plans - newser.com
What momentum shifts mean for Clearmind Medicine Inc.2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
Best data tools to analyze Clearmind Medicine Inc. stockInsider Selling & Weekly Return Optimization Plans - newser.com
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):